These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10432992)

  • 21. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).
    Thomas CR; Weiden PL; Traverso LW; Thompson T
    Am J Clin Oncol; 1997 Apr; 20(2):161-5. PubMed ID: 9124192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma.
    Hoffman JP; Weese JL; Solin LJ; Agarwal P; Engstrom P; Scher R; Paul AR; Litwin S; Watts P; Eisenberg BL
    Am Surg; 1993 Nov; 59(11):772-80; discussion 780-1. PubMed ID: 7902052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer.
    Aristu J; Cañón R; Pardo F; Martínez-Monge R; Martin-Algarra S; Manuel Ordoñez J; Villafranca E; Moreno M; Cambeiro M; Azinovic I
    Am J Clin Oncol; 2003 Feb; 26(1):30-6. PubMed ID: 12576921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas.
    Lee JH; Whittington R; Williams NN; Berry MF; Vaughn DJ; Haller DG; Rosato EF
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):945-53. PubMed ID: 10863064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicities and effects of involved-field irradiation with concurrent cisplatin for unresectable carcinoma of the pancreas.
    Kawakami H; Uno T; Isobe K; Ueno N; Aruga T; Sudo K; Yamaguchi T; Saisho H; Kawata T; Ito H
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1357-62. PubMed ID: 16029793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection].
    Delpero JR; Turrini O
    Cancer Radiother; 2006 Nov; 10(6-7):462-70. PubMed ID: 16987678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
    Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Picozzi VJ; Kozarek RA; Traverso LW
    Am J Surg; 2003 May; 185(5):476-80. PubMed ID: 12727570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.
    Snady H; Bruckner H; Cooperman A; Paradiso J; Kiefer L
    Cancer; 2000 Jul; 89(2):314-27. PubMed ID: 10918161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma.
    Hall WA; Colbert LE; Liu Y; Gillespie T; Lipscomb J; Hardy C; Kooby DA; Prabhu RS; Kauh J; Landry JC
    Cancer; 2013 Jun; 119(12):2350-7. PubMed ID: 23625519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer.
    Garton GR; Gunderson LL; Nagorney DM; Donohue JH; Martin JK; McIlrath DC; Cha SS
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1153-7. PubMed ID: 8262841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3D-Ct-planned interstitial HDR brachytherapy + percutaneous irradiation and chemotherapy in inoperable pancreatic carcinoma. Methods and clinical outcome].
    Pfreundner L; Baier K; Schwab F; Willner J; Bratengeier K; Flentje M; Feustel H; Fuchs KH
    Strahlenther Onkol; 1998 Mar; 174(3):133-41. PubMed ID: 9524622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.
    Kresl JJ; Schild SE; Henning GT; Gunderson LL; Donohue J; Pitot H; Haddock MG; Nagorney D
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):167-75. PubMed ID: 11777635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer.
    Magnin V; Moutardier V; Giovannini MH; Lelong B; Giovannini M; Viret F; Monges G; Bardou VJ; Alzieu C; Delpero JR
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1300-4. PubMed ID: 12654441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil.
    Foo ML; Gunderson LL; Nagorney DM; McLlrath DC; van Heerden JA; Robinow JS; Kvols LK; Garton GR; Martenson JA; Cha SS
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):483-9. PubMed ID: 8390422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival and local control after intraoperative radiation therapy and postoperative radiotherapy: a multivariate analysis of 46 patients undergoing surgery for pancreatic head cancer.
    Alfieri S; Morganti AG; Di Giorgio A; Valentini V; Bossola M; Trodella L; Cellini N; Doglietto GB
    Arch Surg; 2001 Mar; 136(3):343-7. PubMed ID: 11231859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.